Alisporivir Has Limited Antiviral Effects Against Ebola Virus Strains Makona and Mayinga.

about

Characterization of the anti-hepatitis C virus activity of new non-peptidic small-molecule cyclophilin inhibitors with a potential for broad anti-Flaviviridae activity.Advances in Designing and Developing Vaccines, Drugs, and Therapies to Counter Ebola Virus

P2860

Q54212189-EAEAA4E6-94F8-48C6-99FA-7D6EF1D42AB5 Q56535662-A382577B-FB43-459B-AB36-3D08492CE114

P2860

Alisporivir Has Limited Antiviral Effects Against Ebola Virus Strains Makona and Mayinga.

Item

http://www.wikidata.org/entity/Q40093218

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Alisporivir Has Limited Antiviral Effects Against Ebola Virus Strains Makona and Mayinga.

@en

type

Item

label

Alisporivir Has Limited Antiviral Effects Against Ebola Virus Strains Makona and Mayinga.

@en

prefLabel

Alisporivir Has Limited Antiviral Effects Against Ebola Virus Strains Makona and Mayinga.

@en

P1476

Alisporivir Has Limited Antiviral Effects Against Ebola Virus Strains Makona and Mayinga.

@en

P2093

Abhilash I Chiramel

http://www.w3.org/2001/XMLSchema#string

Dominique Brees

http://www.w3.org/2001/XMLSchema#string

Jonathan D Dougherty

http://www.w3.org/2001/XMLSchema#string

Logan Banadyga

http://www.w3.org/2001/XMLSchema#string

R Travis Taylor

http://www.w3.org/2001/XMLSchema#string

Sonja M Best

http://www.w3.org/2001/XMLSchema#string

P2860

Cyclosporine Inhibits Flavivirus Replication through Blocking the Interaction between Host Cyclophilins and Viral NS5 Protein

The combination of alisporivir plus an NS5A inhibitor provides additive to synergistic anti-hepatitis C virus activity without detectable cross-resistance.

Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430.

Cyclophilin A associates with enterovirus-71 virus capsid and plays an essential role in viral infection as an uncoating regulator

EBOLA VACCINE. VSV-EBOV rapidly protects macaques against infection with the 2014/15 Ebola virus outbreak strain.

Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys.

TRIM79α, an interferon-stimulated gene product, restricts tick-borne encephalitis virus replication by degrading the viral RNA polymerase

Infectious disease. Combating emerging viral threats.

Low-dose ribavirin potentiates the antiviral activity of favipiravir against hemorrhagic fever viruses

Determination and Therapeutic Exploitation of Ebola Virus Spontaneous Mutation Frequency.

P304

S355-S359

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/INFDIS/JIW241

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

suppl 3

http://www.w3.org/2001/XMLSchema#string

P478

214

http://www.w3.org/2001/XMLSchema#string

P50

Hideki Ebihara

Darryl Falzarano

Cynthia Martellaro

P577

2016-08-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27511894

http://www.w3.org/2001/XMLSchema#string

P921

Ebola virus

P932

5050471

http://www.w3.org/2001/XMLSchema#string

Alisporivir Has Limited Antiviral Effects Against Ebola Virus Strains Makona and Mayinga.

about

P2860

P2860

Alisporivir Has Limited Antiviral Effects Against Ebola Virus Strains Makona and Mayinga.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932